Ticker: ELAN

Elanco Animal Health Incorporated (NYSE: ELAN) - Q2 2025 Financial Report Key Financial Metrics: Revenue: $1,241 million (up 5% YoY); Total revenue for the first half: $2,434 million (up 2% YoY). Net Income: $11 million (compared to a net loss of $50 million in Q2 2024); Six-month net income is ...

Elanco Animal Health Incorporated (NYSE: ELAN) has recently released its Q1 2025 financial results, reflecting a mixed performance in various metrics. The company is facing both challenges and opportunities in the highly competitive animal health market. Positive Aspects: Revenue: $1,193 million...